The North America biobanking market size surpassed USD 29.15 billion in 2025 and is predicted to reach around USD 69.64 billion by 2035, registering a CAGR of 9.1% from 2026 to 2035. The market is mainly fueled by the swift growth of precision medicine and population genomics initiatives, which need extensive, high-quality biospecimen storage.

North America Biobanking Market Statical Scope

The market is vital for promoting personalized medicine , drug development, and regenerative medicine by keeping large quantities of biological samples for research purposes. It plays a key role in investigating diseases such as cancer and Alzheimer's, spurred by a strong need for targeted treatments and progress in genomics.

As stem cell practices increase, biobanks are essential for storing cord blood and other stem cells for therapies , particularly for rare genetic diseases and chronic illnesses. The market is at the forefront of implementing automated, high-throughput, and digital storage solutions, which enhance operational efficiency in managing samples.

North America Biobanking Market Share, By Sample Storage, 2025 (%)

• Blood - With a 45.00% share, the blood products segment is the leading segment of the North American biobanking market. This is due to its flexibility, standardized collection techniques, and high demand in research. Blood-derived biospecimens are crucial for advancing precision medicine, genomics, and infectious disease research.
• Cells & Tissues - Holding a 35.00% share, the cells and tissues segment plays a key role in the North American biobanking market. It is fundamental to the region's fast-growing regenerative medicine, personalized therapies, and oncology research. Human tissues account for the largest revenue share in the biobanking market, driven by their critical role in disease modeling and biomarker validation.

North America Biobanking Market Share, By Application, 2025 (%)

• Regenerative Medicines - With a dominant 50.00% share, the regenerative medicine segment is a major segment in the North American biobanking market. Stem cell banking is anticipated to grow quickly due to the increasing need for therapies to treat chronic, genetic, and degenerative diseases. Biobanking offers the necessary framework for preserving high-quality stem cells, tissues, and genetic materials essential for developing advanced therapies.
• Life Science - Holding a 40.00% share, the Life Science segment is vital to the North American biobanking market. It provides the crucial infrastructure, including equipment, storage supplies, and digital management systems, needed to support the region's growing investments in personalized medicine, oncology, and cell/gene therapy. This segment facilitates high-quality biospecimen storage, promoting drug discovery and research.

North America Biobanking Market Share, By Settings, 2025 (%)

• Academic Medical Institutions - Academic medical institutions hold a significant 60.00% market share, playing a dominant role in this sector through extensive research, numerous clinical collaborations, and the establishment of standardized biorepositories for precision medicine. These institutions enhance the market by combining patient samples with long-term clinical data, serving as a key source for discovering biomarkers and developing drugs.
• Pharmaceutical & Biotechnological Companies - The Pharmaceutical & Biotechnological Companies segment accounts for a 40.00% share in the North American Biobanking Market. This segment is essential as these companies are the main users of biobanked samples, which are crucial for drug discovery, enriching clinical trials, and advancing personalized medicine.

Top Companies in the North America Biobanking Market

• Thermo Fisher Scientific Inc.
• Tecan Trading AG
• QIAGEN
• Hamilton Company
• Brooks Life Sciences
• TTP Labtech
• VWR International, LLC.
• Promega Corporation
• Worthington Industries
• BD
• Merck KGaA
• Biokryo GmbH
• Cell&Co BioServices
• RUCDR Infinite Biologics
• Modul-Bio

Segments Covered in the Report

By Sample Storage

• Blood
• Cells & Tissues
• Others

By Application

• Regenerative Medicines
• Life Science
• Others

By Settings

• Academic Medical Institutions
• Pharmaceutical & Biotechnological Companies